UK markets closed
  • FTSE 100

    7,765.15
    +4.04 (+0.05%)
     
  • FTSE 250

    20,035.39
    +119.89 (+0.60%)
     
  • AIM

    869.24
    +3.83 (+0.44%)
     
  • GBP/EUR

    1.1399
    +0.0010 (+0.09%)
     
  • GBP/USD

    1.2394
    -0.0013 (-0.10%)
     
  • BTC-GBP

    19,159.47
    +497.64 (+2.67%)
     
  • CMC Crypto 200

    526.66
    +9.65 (+1.87%)
     
  • S&P 500

    4,070.56
    +10.13 (+0.25%)
     
  • DOW

    33,978.08
    +28.68 (+0.08%)
     
  • CRUDE OIL

    79.38
    -0.30 (-0.38%)
     
  • GOLD FUTURES

    1,943.90
    -1.70 (-0.09%)
     
  • NIKKEI 225

    27,382.56
    +19.76 (+0.07%)
     
  • HANG SENG

    22,688.90
    +122.10 (+0.54%)
     
  • DAX

    15,150.03
    +17.23 (+0.11%)
     
  • CAC 40

    7,097.21
    +1.22 (+0.02%)
     

The Worldwide Self-injection Device Industry is Expected to Reach $92 Billion by 2027: Benefits and Convenience Leading To Increased Demand For Self Injectors

Company Logo
Company Logo

Global Self-injection Device Market

Global Self-injection Device Market
Global Self-injection Device Market

Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Self-injection Device Market (2022-2027) by Type, Usage, Therapeutic Areas Application, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Self-injection Device Market is estimated to be USD 45.94 Bn in 2022 and expected to reach USD 92.24 Bn by 2027, growing at a CAGR of 14.96%.

Market dynamics are forces that impact the prices and behaviors of the Global Self-injection Device Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Becton, Dickinson, and Co., Cipla Inc., Eli Lilly and Co., Enable Injections, Inc., Merck & Co. Inc., Novartis Ag, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Self-injection Device Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Self-injection Device Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Self-injection Device Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.

  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.

  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Attribute

Details

No. of Pages

153

Forecast Period

2022 - 2027

Estimated Market Value (USD) in 2022

$45.94 Billion

Forecasted Market Value (USD) by 2027

$92.24 Billion

Compound Annual Growth Rate

14.9%

Regions Covered

Global

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Rapid Prevalence of Chronic Diseases and Rheumatoid Arthritis
4.1.2 Benefits and Convenience Leading To Increased Demand For Self Injectors
4.2 Restraints
4.2.1 Strict Regulation for Patent Approval
4.3 Opportunities
4.3.1 Technological Advancements in Self-Injection Devices
4.3.2 Development of Biologic Drugs to Treat Autoimmune Diseases
4.3.3 Increase in Diabetes and the Growing Pressure on Health Care Costs
4.4 Challenges
4.4.1 Availability of Alternative Delivery Methods

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis

6 Global Self-injection Device Market, By Type
6.1 Introduction
6.2 Auto-Injectors
6.3 Needle-free Injectors
6.4 Pen Injectors
6.5 Wearable Injectors

7 Global Self-injection Device Market, By Usage
7.1 Introduction
7.2 Disposable
7.3 Reusable

8 Global Self-injection Device Market, By Therapeutic Areas Application
8.1 Introduction
8.2 Autoimmune Diseases
8.2.1 AIDS
8.2.2 Allergies
8.2.3 Cancer
8.2.4 Irritable Bowel Disorders
8.2.5 Multiple Sclerosis
8.2.6 Psoriasis
8.2.7 Parkinson's
8.3 Emergency Drugs
8.3.1 Anaphylactic Shocks
8.3.2 Migraine
8.4 Hormone Replacement Therapies
8.4.1 Beta-Interferon
8.4.2 Erythropoietin
8.4.3 Follicle Stimulating Hormone
8.4.4 Heparin
8.4.5 Insulin
8.4.6 Parathyroid Hormone
8.5 Pain Management

9 Americas' Self-injection Device Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas

10 Europe's Self-injection Device Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe

11 Middle East and Africa's Self-injection Device Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA

12 APAC's Self-injection Device Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements

14 Company Profiles
14.1 AbbVie, Inc.
14.2 Advanz Pharma Corp.
14.3 Amgen Inc.
14.4 Antares Pharma, Inc.
14.5 AstraZeneca PLC
14.6 Bayer Ag
14.7 Becton, Dickinson, and Co.
14.8 Cipla Inc.
14.9 Eli Lilly and Co.
14.10 Enable Injections, Inc.
14.11 Gerresheimer Ag
14.12 GSK PLC
14.13 Haselmeier Ag
14.14 Health Biotech Ltd.
14.15 Intrapharm Laboratories Ltd.
14.16 Merck & Co. Inc.
14.17 Novartis Ag
14.18 NuGen Medical Devices
14.19 Owen Mumford Ltd.
14.20 Pfizer, Inc.
14.21 SHL Medical Ag
14.22 Sumitomo Pharma Co. Ltd.
14.23 Terumo Corp.
14.24 Ypsomed Ag

15 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ysw3zs

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900